Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-23

Clinical Trial Update: Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China [NA]

View source ↗

Summary

A completed clinical trial evaluating efavirenz in combination with lamivudine/zidovudine for treatment-naive HIV infection in Wenxi County, Shanxi Province, Ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFAVIRENZ (efavirenz)
  • Lamivudine/Zidovudine (lamivudine; zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | NA | Status: COMPLETED